RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%
Last update at 2024-05-16T18:26:00Z
| Breakdown | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
| Income before tax | -5.88107M | -8.61032M | -0.62668M | -0.42193M | -1.23615M |
| Minority interest | - | - | - | - | - |
| Net income | -5.88107M | -8.61032M | -0.62668M | -0.42193M | -1.23615M |
| Selling general administrative | 4.94M | 7.17M | 0.60M | 0.35M | 1.16M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 0.06M | 0.00388M | - | 0.00690M | 0.01M |
| Reconciled depreciation | 0.15M | 0.06M | 0.00298M | 0.00279M | - |
| Ebit | -5.83637M | -8.59376M | -0.61011M | -0.40282M | -1.22734M |
| Ebitda | -5.72800M | -8.55234M | -0.60631M | -0.40024M | -1.23608M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | -5.83637M | -8.59376M | -0.61011M | -0.40282M | -1.23608M |
| Other operating expenses | - | - | - | - | - |
| Interest expense | 0.00138M | 0.00000M | 0.02M | 0.02M | 0.00000M |
| Tax provision | - | - | - | - | - |
| Interest income | - | - | - | - | - |
| Net interest income | -0.00138M | 0.00000M | -0.01740M | -0.01891M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | - | - | - | - | - |
| Total revenue | 0.14M | 0.00388M | 0.00378M | 0.00690M | 0.01M |
| Total operating expenses | 5.98M | 8.60M | 0.61M | 0.41M | 1.25M |
| Cost of revenue | 0.08M | 0.00000M | - | - | - |
| Total other income expense net | -0.04332M | -0.01656M | 0.00082M | -0.00020M | -0.00008M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -5.88107M | -8.61032M | -0.62668M | -0.42193M | -1.23615M |
| Net income applicable to common shares | -5.88107M | -8.61032M | -0.62668M | -0.42193M | -1.23615M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
| Total assets | 2.21M | 4.00M | 2.24M | 1.15M | 0.08M |
| Intangible assets | 0.62M | 0.11M | - | 0.04M | 0.05M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | - | - | - | - |
| Total liab | 2.16M | 1.25M | 0.93M | 0.92M | 0.37M |
| Total stockholder equity | 0.04M | 2.75M | 1.32M | 0.22M | -0.28640M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | - | - | - | - | - |
| Common stock | - | 20.86M | 18.91M | 12.11M | 10.97M |
| Capital stock | 21.83M | 20.86M | 18.91M | 12.11M | 10.97M |
| Retained earnings | -35.77765M | -32.00988M | -26.12880M | -17.51848M | -16.89180M |
| Other liab | - | - | - | - | - |
| Good will | - | - | - | - | - |
| Other assets | - | 0.20M | - | - | - |
| Cash | 0.18M | 3.08M | 1.78M | 1.06M | 0.03M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 2.14M | 1.16M | 0.89M | 0.88M | 0.29M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | - | - | - | - | 0.06M |
| Short term debt | - | - | - | - | 0.00700M |
| Short long term debt | 0.04M | - | - | 0.06M | 0.00700M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | - | 13.90M | 8.53M | 5.64M | 5.64M |
| Property plant equipment | - | 0.11M | 0.08M | 0.00201M | 0.00252M |
| Total current assets | 0.45M | 3.58M | 1.95M | 1.10M | 0.03M |
| Long term investments | 0.84M | - | - | - | - |
| Net tangible assets | - | 2.64M | 1.11M | 0.18M | -0.33367M |
| Short term investments | - | - | - | - | - |
| Net receivables | 0.00000M | 0.25M | 0.10M | - | - |
| Long term debt | - | 0.04M | 0.04M | 0.04M | 0.08M |
| Inventory | 0.17M | 0.17M | 0.05M | 0.02M | - |
| Accounts payable | 1.43M | 0.34M | 0.49M | 0.55M | 0.21M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | - | - | - | 0.05M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1.76M | 0.42M | 0.29M | 0.05M | 0.05M |
| Capital lease obligations | 0.05M | 0.07M | 0.00000M | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
| Investments | -0.20493M | -0.30000M | 0.00000M | -0.00308M | -0.04949M |
| Change to liabilities | 0.68M | 1.27M | 0.54M | 0.03M | 0.22M |
| Total cashflows from investing activities | -0.20493M | -0.30000M | -0.30000M | -0.00308M | -0.04949M |
| Net borrowings | -0.00560M | -0.05594M | 0.09M | -0.00150M | 0.24M |
| Total cash from financing activities | 5.31M | 3.87M | 1.14M | -0.00150M | 0.57M |
| Change to operating activities | -0.09286M | -0.11295M | -0.02373M | 0.08M | 0.03M |
| Net income | -5.88107M | -8.61032M | -0.62668M | -0.42193M | -1.23615M |
| Change in cash | 1.30M | 0.72M | 1.03M | -0.19430M | 0.16M |
| Begin period cash flow | 1.78M | 1.06M | 0.03M | 0.22M | 0.07M |
| End period cash flow | 3.08M | 1.78M | 1.06M | 0.03M | 0.22M |
| Total cash from operating activities | -3.80000M | -2.85551M | -0.10494M | -0.18972M | -0.35989M |
| Issuance of capital stock | 5.31M | 3.93M | - | 0.00000M | - |
| Depreciation | 0.15M | 0.06M | 0.00298M | 0.00279M | 0.00279M |
| Other cashflows from investing activities | -0.20493M | -0.20493M | -0.20493M | -0.20493M | - |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -0.12152M | -0.03400M | -0.01720M | -0.01720M | -0.01720M |
| Change to account receivables | -0.11506M | -0.11506M | -0.11506M | -0.11506M | - |
| Sale purchase of stock | - | - | - | - | - |
| Other cashflows from financing activities | - | - | - | - | - |
| Change to netincome | 1.58M | 4.57M | 0.02M | 0.12M | 0.62M |
| Capital expenditures | 0.00000M | 0.10M | 0.10M | 0.00308M | 0.00308M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 0.35M | 1.12M | 0.50M | 0.11M | 0.88M |
| Stock based compensation | 1.57M | 4.57M | 0.00000M | 0.10M | - |
| Other non cash items | 0.00138M | - | 0.02M | 0.02M | - |
| Free cash flow | -3.80000M | -3.15551M | -0.10494M | -0.19280M | -0.40938M |
Sector: Healthcare Industry: Medical Devices
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| THRM Therma Bright Inc |
- -% | 0.01 | - | - | 321.86 | 4.06 | 325.26 | -2.3755 |
| PINK Perimeter Medical Imaging AI Inc |
-0.01 1.75% | 0.56 | - | - | 117.72 | 2.89 | 122.12 | -4.2252 |
| VPT VentriPoint Diagnostics Ltd |
-0.005 2.22% | 0.22 | - | - | 1376.49 | 34.01 | 1193.16 | -9.1712 |
| TLT Theralase Technologies Inc. |
-0.005 3.03% | 0.16 | - | - | 35.41 | 23.10 | 36.69 | -9.1528 |
| ASG Aurora Spine Corp |
0.01 3.77% | 0.28 | - | - | 1.83 | 5.11 | 2.14 | -31.4665 |
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It also offers Inretio, a medical device for ischemic stroke treatment; Digital Cough Test (DCT), an app that uses artificial intelligence to detect multiple respiratory diseases; and inhaled statin therapy for the treatment of COVID-19 pneumonia and acute respiratory distress syndrome in hospitalized patients. The company serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.
1173 Dundas Street East, Toronto, ON, Canada, M4M 3P1
| Name | Title | Year Born |
|---|---|---|
| Mr. Roberto Fia C.F.A. | Chairman, Pres & CEO | 1970 |
| Mr. Victor Hugo C.M.A., CPA | Chief Financial Officer | 1970 |
| Mr. Michael Mayo | Director of Sales | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
CA 
AU
UK
US
NZ
Please wait processing your request...